These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19949267)

  • 21. Assessment of fracture risk.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Eur J Radiol; 2009 Sep; 71(3):392-7. PubMed ID: 19716672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for the prevention of osteoporosis and fragility fractures. International comparison and synthesis.
    Rossignol M; Moride Y; Perreault S; Boivin JF; Ste-Marie LG; Robitaille Y; Poulin de Courval L; Fautrel B
    Int J Technol Assess Health Care; 2002; 18(3):597-610. PubMed ID: 12391952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Absolute risk for fracture and WHO guideline. WHO model for assessing absolute risk of fracture].
    Iki M;
    Clin Calcium; 2007 Jul; 17(7):1015-21. PubMed ID: 17607067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
    Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation.
    Czerwiński E; Badurski JE; Marcinowska-Suchowierska E; Osieleniec J
    Ortop Traumatol Rehabil; 2007; 9(4):337-56. PubMed ID: 17882114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Criteria for initiation of pharmacological treatment by Japanese 2011 guidelines for prevention and treatment of osteoporosis].
    Hagino H
    Clin Calcium; 2014 Mar; 24(3):339-47. PubMed ID: 24576930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survey of spine surgeons on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis.
    Dipaola CP; Bible JE; Biswas D; Dipaola M; Grauer JN; Rechtine GR
    Spine J; 2009 Jul; 9(7):537-44. PubMed ID: 19328744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of fracture risk: who should be treated for osteoporosis?
    van der Klift M; de Laet CD; Pols HA
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):937-50. PubMed ID: 16301188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical risk factors and evaluation of the risk of osteoporosis in clinical practice.
    McClung MR
    Ann Med Interne (Paris); 2000 Sep; 151(5):392-8. PubMed ID: 11033474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of Novel Osteoporosis Screening Methods Using FRAX].
    Yamamoto N; Tsuchiya H
    Yakugaku Zasshi; 2019; 139(1):35-38. PubMed ID: 30606925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Bone mineral measurements and guideline].
    Fukunaga M; Sone T
    Clin Calcium; 2008 Aug; 18(8):1089-95. PubMed ID: 18677045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress in the treatment of osteoporosis].
    Sugimoto T
    Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Staged diagnosis in osteoporosis. Is your patient at risk for fractures?].
    Seibel MJ
    MMW Fortschr Med; 2001 Nov; 143(47):26-30. PubMed ID: 11791357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [FRAX--model for 10-year fracture risk assessment. Support in the treatment of osteoporosis, according to preliminary Swedish guidelines].
    Johansson H; Kanis JA; Ljunggren O; Ström O; Svensson O; Mellström D
    Lakartidningen; 2011 Feb 16-22; 108(7):336-9. PubMed ID: 21539116
    [No Abstract]   [Full Text] [Related]  

  • 35. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
    Ott C; Fulton MK
    J Am Acad Nurse Pract; 2005 Mar; 17(3):113-22. PubMed ID: 15748224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactose intolerance: a risk factor for reduced bone mineral density and vertebral fractures?
    Kudlacek S; Freudenthaler O; Weissböeck H; Schneider B; Willvonseder R
    J Gastroenterol; 2002; 37(12):1014-9. PubMed ID: 12522532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New paradigm for treatment and prevention of osteoporosis].
    Nakamura T
    Clin Calcium; 2008 Aug; 18(8):1077. PubMed ID: 18810857
    [No Abstract]   [Full Text] [Related]  

  • 38. Emerging concepts in osteoporosis and bone strength.
    Rubin CD
    Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practice guidelines on the use of bone mineral density measurements: Who to test? What measures to use? When to treat? A consensus report from the Middle East Densitometry Workshop.
    El-Hajj Fuleihan G; Baddoura R; Awada H; Okais J; Rizk P; McClung M;
    J Med Liban; 2002; 50(3):89-104. PubMed ID: 14640175
    [No Abstract]   [Full Text] [Related]  

  • 40. Osteoporosis--Part I: Risk factors and screening.
    Moyad MA
    Urol Nurs; 2002 Aug; 22(4):276-9. PubMed ID: 12242900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.